Ligand validation:6LTV

3PO: TRIPHOSPHATE

3PO is a Ligand Of Interest in 6LTV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LTV_3PO_A_501	88%	38%	0.115	0.99	1.12	1.3	-	1	0	0	100%	1
6LTV_3PO_B_501	86%	39%	0.114	0.984	0.8	1.54	-	3	0	0	100%	1
4ODJ_3PO_A_501	95%	40%	0.083	0.986	0.94	1.38	-	3	2	0	100%	1
5A66_3PO_B_1000	96%	34%	0.08	0.99	1.04	1.54	-	2	0	0	100%	1
3CI3_3PO_A_901	96%	53%	0.079	0.987	0.84	0.99	-	1	2	0	100%	0.9
5T8S_3PO_B_404	95%	50%	0.077	0.981	0.65	1.25	-	2	0	0	100%	0.91
5A5Y_3PO_A_1000	94%	44%	0.086	0.985	0.86	1.3	-	1	0	0	100%	1
5A60_3PO_A_1000	93%	44%	0.096	0.99	0.78	1.38	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.